An Improved Spectrophotometric Method for Toluene-4-Monooxygenase Activity
- PMID: 36593585
- PMCID: PMC10423644
- DOI: 10.1002/chem.202203322
An Improved Spectrophotometric Method for Toluene-4-Monooxygenase Activity
Abstract
Monooxygenases, an important class of enzymes, have been the subject of enzyme engineering due to their high activity and versatile substrate scope. Reactions performed by these biocatalysts have long been monitored by a colorimetric method involving the coupling of a dye precursor to naphthalene hydroxylation products generated by the enzyme. Despite the popularity of this method, we found the dye product to be unstable, preventing quantitative readout. By incorporating an extraction step to solubilize the dye produced, we have improved this assay to the point where quantitation of enzyme activity is possible. Further, by incorporating spectral deconvolution, we have, for the first time, enabled independent quantification of the two possible regioisomeric products: 1-naphthol and 2-naphthol. Previously, such analysis was only possible with chromatographic separation, increasing the cost and complexity of analysis. The efficacy of our improved workflow was evaluated by monitoring the activity of a toluene-4-monooxygenase enzyme from Pseudomonas mendocina KR-1. Our colorimetric regioisomer quantification was found to be consistent with chromatographic analysis by HPLC. The development and validation of a quantitative colorimetric assay for monooxygenase activity that enables regioisomeric distinction and quantification represents a significant advance in analytical methods to monitor enzyme activity. By maintaining facile, low-cost, high-throughput readout while incorporating quantification, this assay represents an important alternative to more expensive chromatographic quantification techniques.
Keywords: HPLC; UV-Vis spectroscopy; analytical chemistry; cloning; colorimetric assay; enzyme; monooxygenase; regiospecificity.
© 2023 The Authors. Chemistry - A European Journal published by Wiley-VCH GmbH.
Conflict of interest statement
Conflict of Interest:
The authors declare that they have no conflicts of interest with the contents of this article.
Figures




References
-
- Bell EL, Finnigan W, France SP, Green AP, Hayes MA, Hepworth LJ, Lovelock SL, Niikura H, Osuna S, Romero E, Ryan KS, Turner NJ, Flitsch SL, Nat. Rev. Methods Prim 2021, 1, 1–21.
-
- Winkler M, Glieder A, Fraaije MW, 2010, 146, 9–24. - PubMed
-
- Rosenzweig AC, Frederick CA, Lippard SJ, Nordlund P, Nature 1993, 366, 537–543. - PubMed
-
- Zanger UM, Schwab M, Pharmacol. Ther 2013, 138, 103–141. - PubMed
-
- Coleman T, Kirk AM, Chao RR, Podgorski MN, Harbort JS, Churchman LR, Bruning JB, Bernhardt PV, Harmer JR, Krenske EH, De Voss JJ, Bell SG, ACS Catal 2021, 11, 1995–2010.
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources